Skip to content

MED & SKIN

Active Private limited companyfounded 2017active for 9 yearsSteenweg op Etterbeek 168, 1040 EtterbeekKBO/BCE: BE 0682.805.368

Lifetime

7 annual accounts with figures on one time axis
peak of €169,184 in 2023
€62,265▼ 50.9%
lowest -€86,009 in 2019
-€46,407▼ €51,147
peak of €119,316 in 2024
€72,909▼ 38.9%
€372,638▲ 48.0%
peak of 4 FTE in 2025
4 FTE 
Board1 name since 2018
1 director
Documentsfilings and deeds
24-07-2026174 days late
2025abbreviated format
Gross margin from €126,909 to €62,265Loss of €46,407Equity from €119,316 to €72,909Debts from €251,801 to €372,638Cash from €45,952 to €27,902

Key points

from the 2025 annual accounts

Result

-€46,407 -€46,407
€4,7402024-€46,4002025

From profit to loss in 2025, after a profit of €4,740 in 2024.

Debts

€372,638 84% of the balance sheet
Financial debts 63%Suppliers 7%Taxes and wages 7%Other 24%

Of this, €129,342 falls due within a year.

Filings

7 annual accounts 174 days
deadline202020222024

Latest accounts filed late: after the legal deadline.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,134 companies had the same profile as MED & SKIN has now. Each dot stands for 3 companies, two years later.

86.3%
were still trading
6.6%
stopped another way
6.8%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a loss of 10% of the balance sheet or more

Another 0.3% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,134 companies, not a prediction for MED & SKIN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 318 sharesdeed of 22-10-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0682805368
Transfer of 318 shares from to resigns as director · General meeting of 30-09-2024 · Gazette deed
(director) and (director) change roles Discharge granted to · Discharge granted to · General meeting of 16-01-2024 · Gazette deed
appointed as manager General meeting of 25-06-2021 · Gazette deed
All 17 events

Comparable companies

same main activity, similar in size and age
Company
MED & SKIN Etterbeek €0.8m -5.1% 16.4% 4
WBA Optique Braine-l'Alleud - - 12.5% 3.7
CDI MEDICAL Namur - - -354.2% 4.3
PROXYMED MEDICAL CONSULTING SOLUTION Molenbeek-Saint-Jean - - 27.9% -
GINGENROOTS Anderlecht - - 9.5% -
Matériel médical Thierry Ernst Dalhem - - 66.7% 1.3
BEKA Hospitec Lede €2.9m 6.3% 25.0% 4
-10%0%10%20%€1m€10m€100m€1bnMED & SKINEBIT margin

Grey: the largest companies of the sector (retail trade (NACE 47)), without their names. Blue: the sector peers from the table.

These companies have the same main activity as MED & SKIN: retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741). They are comparable in size and age: total assets between €179,000 and €1.4m, founded between 2016 and 2019.

Official details

Source: KBO
Status
Active since 11-10-2017Normal situation
Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lensesNACE 47741and 5 others
Joint committee
207White-collar workers in the chemical industry · annual accounts 30-06-2024
Establishment unit
2.272.346.5461040 Etterbeek, registered on 01-01-2018
Financial year end
30 June
Peppol
Reachable since 03-01-2026
Company details

Annual accounts to 30-06-2025

€445,547▲ 20.1%
Filing
Filed on 24-07-2026
Financials

Insights on MED & SKIN

MED & SKIN files the abbreviated format. The filing also states the turnover: €831,755 in 2025. The gross margin rose from -€13,532 in 2019 to €62,265 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MED & SKIN

What is the company number of MED & SKIN?
The company number of MED & SKIN is 0682.805.368. The VAT number is the same number with BE in front: BE 0682.805.368.
Where is MED & SKIN based?
The registered office is at Steenweg op Etterbeek 168, 1040 Etterbeek.Company details
What does MED & SKIN do?
According to the KBO register, the main activity is retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741).
What is the legal form of MED & SKIN?
MED & SKIN is a private limited company (BV).
When was MED & SKIN founded?
MED & SKIN was founded on 11-10-2017.
Is MED & SKIN still active?
Yes, MED & SKIN is an active enterprise in the KBO register.
How many employees does MED & SKIN have?
MED & SKIN had an average of 4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does MED & SKIN fall under?
In its 30-06-2024 annual accounts, MED & SKIN states joint committee 207 (White-collar workers in the chemical industry).
What is the turnover of MED & SKIN?
The turnover of MED & SKIN was €831,755 in financial year 2025, according to the filed annual accounts.
Is MED & SKIN profitable?
In financial year 2025, MED & SKIN made a loss of €46,407.
Where can I find the annual accounts of MED & SKIN?
MED & SKIN filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MED & SKIN due?
MED & SKIN must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.